Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$151M |
| 2 |
GE Vernova
GEV
|
+$139M |
| 3 |
Ferrovial SE
FER
|
+$60.1M |
| 4 |
Strategy Inc Common Stock Class A
MSTR
|
+$24M |
| 5 |
Solventum
SOLV
|
+$22.9M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$184M |
| 2 |
GE Aerospace
GE
|
+$135M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Microsoft
MSFT
|
+$110M |
| 5 |
Meta Platforms (Facebook)
META
|
+$80.5M |
Sector Composition
| 1 | Technology | 33.84% |
| 2 | Healthcare | 12.16% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Communication Services | 9.35% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Pacira BioSciences
PCRX
$1.22B
| $2.61M | ﹤0.01% |
91,400
| – | – |
|
|
JBGS
1677
JBG SMITH
JBGS
$1.45B
| $2.61M | ﹤0.01% |
171,358
-8,100
| -5% | -$123K |
|
1678
Keros Therapeutics
KROS
$636M
| $2.6M | ﹤0.01% |
56,800
+6,900
| +14% | +$315K |
|
|
ARI
1679
Apollo Commercial Real Estate
ARI
$1.51B
| $2.59M | ﹤0.01% |
264,639
| – | – |
|
1680
First Bancorp
FBNC
$2.29B
| $2.59M | ﹤0.01% |
81,000
| – | – |
|
1681
AMC Entertainment Holdings
AMC
$1.44B
| $2.58M | ﹤0.01% |
518,391
+127,500
| +33% | +$635K |
|
1682
NETSCOUT
NTCT
$1.8B
| $2.56M | ﹤0.01% |
140,128
| – | – |
|
|
ZUO
1683
DELISTED
Zuora, Inc.
ZUO
| $2.56M | ﹤0.01% |
257,500
+4,300
| +2% | +$42.7K |
|
1684
Montrose Environmental
MEG
$1.05B
| $2.55M | ﹤0.01% |
57,300
+800
| +1% | +$35.6K |
|
1685
Westamerica Bancorp
WABC
$1.24B
| $2.55M | ﹤0.01% |
52,500
| – | – |
|
1686
Empire State Realty Trust
ESRT
$1.34B
| $2.54M | ﹤0.01% |
271,100
| – | – |
|
|
LADR
1687
Ladder Capital
LADR
$1.48B
| $2.54M | ﹤0.01% |
225,207
| – | – |
|
1688
Hope Bancorp
HOPE
$1.4B
| $2.54M | ﹤0.01% |
236,557
| – | – |
|
1689
Tilray
TLRY
$1.23B
| $2.53M | ﹤0.01% |
1,522,338
+31,400
| +2% | +$52.1K |
|
|
PWSC
1690
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $2.53M | ﹤0.01% |
112,800
| – | – |
|
1691
Vera Therapeutics
VERA
$1.52B
| $2.52M | ﹤0.01% |
69,700
+7,500
| +12% | +$271K |
|
1692
S&T Bancorp
STBA
$1.5B
| $2.52M | ﹤0.01% |
75,400
| – | – |
|
1693
Arvinas
ARVN
$568M
| $2.5M | ﹤0.01% |
94,000
-20,100
| -18% | -$535K |
|
1694
Vital Farms
VITL
$2.17B
| $2.5M | ﹤0.01% |
53,500
+600
| +1% | +$28.1K |
|
1695
Alaska Air
ALK
$7.31B
| $2.5M | ﹤0.01% |
61,900
-1,300
| -2% | -$52.5K |
|
1696
Orion
OEC
$521M
| $2.5M | ﹤0.01% |
113,900
-1,300
| -1% | -$28.5K |
|
1697
Ichor Holdings
ICHR
$579M
| $2.49M | ﹤0.01% |
64,700
| – | – |
|
1698
IES Holdings
IESC
$7.5B
| $2.49M | ﹤0.01% |
17,900
+2,000
| +13% | +$279K |
|
|
INFN
1699
DELISTED
Infinera Corporation Common Stock
INFN
| $2.49M | ﹤0.01% |
409,500
+7,000
| +2% | +$42.6K |
|
1700
Under Armour
UAA
$2.08B
| $2.48M | ﹤0.01% |
371,900
| – | – |
|